Search hospitals

>

Utah

>

Salt Lake City

Primary Children's Hospital

Claim this profile

Salt Lake City, Utah 84113

Global Leader in Cancer

Global Leader in Brain Tumor

Conducts research for Neuroblastoma

Conducts research for Acute Lymphoblastic Leukemia

Conducts research for Solid Tumors

412 reported clinical trials

33 medical researchers

Photo of Primary Children's Hospital in Salt Lake CityPhoto of Primary Children's Hospital in Salt Lake CityPhoto of Primary Children's Hospital in Salt Lake City

Summary

Primary Children's Hospital is a medical facility located in Salt Lake City, Utah. This center is recognized for care of Cancer, Brain Tumor, Neuroblastoma, Acute Lymphoblastic Leukemia, Solid Tumors and other specialties. Primary Children's Hospital is involved with conducting 412 clinical trials across 651 conditions. There are 33 research doctors associated with this hospital, such as Matthew Dietz, Luke D. Maese, Michael Pulsipher, MD, and Priya Chan.

Area of expertise

1

Cancer

Global Leader

Primary Children's Hospital has run 51 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage II
2

Brain Tumor

Global Leader

Primary Children's Hospital has run 48 trials for Brain Tumor. Some of their research focus areas include:

Stage IV
Stage II
Stage I

Top PIs

Clinical Trials running at Primary Children's Hospital

Brain Tumor

Neuroblastoma

Cancer

Wilms Tumor

Testicular cancer

Chronic Kidney Disease

Burkitt Lymphoma

Brain Cancer

Leukemia

Retinoblastoma

Image of trial facility.

Selumetinib vs. Chemotherapy

for Brain Cancer

This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.

Recruiting

2 awards

Phase 3

Image of trial facility.

Selinexor + Radiation

for Brain Cancer

This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.

Recruiting

1 award

Phase 1 & 2

1 criteria

Image of trial facility.

Lower Radiotherapy Dose

for Brain Tumors

This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.

Recruiting

1 award

Phase 2

10 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Primary Children's Hospital?

Where is Primary Children's Hospital located?

Who should I call to ask about financial aid or insurance network?

What insurance does Primary Children's Hospital accept?

What awards or recognition has Primary Children's Hospital received?